全文获取类型
收费全文 | 5753篇 |
免费 | 392篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 214篇 |
妇产科学 | 155篇 |
基础医学 | 888篇 |
口腔科学 | 183篇 |
临床医学 | 658篇 |
内科学 | 956篇 |
皮肤病学 | 39篇 |
神经病学 | 467篇 |
特种医学 | 296篇 |
外科学 | 838篇 |
综合类 | 60篇 |
预防医学 | 360篇 |
眼科学 | 97篇 |
药学 | 428篇 |
中国医学 | 4篇 |
肿瘤学 | 474篇 |
出版年
2022年 | 37篇 |
2021年 | 65篇 |
2020年 | 48篇 |
2019年 | 75篇 |
2018年 | 88篇 |
2017年 | 76篇 |
2016年 | 86篇 |
2015年 | 101篇 |
2014年 | 118篇 |
2013年 | 197篇 |
2012年 | 208篇 |
2011年 | 216篇 |
2010年 | 131篇 |
2009年 | 145篇 |
2008年 | 217篇 |
2007年 | 241篇 |
2006年 | 281篇 |
2005年 | 257篇 |
2004年 | 225篇 |
2003年 | 198篇 |
2002年 | 240篇 |
2001年 | 216篇 |
2000年 | 202篇 |
1999年 | 216篇 |
1998年 | 73篇 |
1997年 | 64篇 |
1996年 | 62篇 |
1995年 | 66篇 |
1994年 | 54篇 |
1993年 | 57篇 |
1992年 | 157篇 |
1991年 | 142篇 |
1990年 | 144篇 |
1989年 | 131篇 |
1988年 | 134篇 |
1987年 | 137篇 |
1986年 | 112篇 |
1985年 | 104篇 |
1984年 | 80篇 |
1983年 | 84篇 |
1982年 | 43篇 |
1981年 | 43篇 |
1980年 | 33篇 |
1979年 | 71篇 |
1978年 | 81篇 |
1977年 | 57篇 |
1976年 | 42篇 |
1975年 | 52篇 |
1974年 | 47篇 |
1971年 | 36篇 |
排序方式: 共有6153条查询结果,搜索用时 15 毫秒
71.
Monoclonal antibodies raised against living, early invasive mouse trophoblast cells were screened on paraffin sections from first- and third-trimester placentas and from hydatidiform moles and choriocarcinoma. Several mouse-human cross-reacting antibodies were recognized, which implies that mouse trophoblast cells can be used as immunogen for producing antibodies against human trophoblast. Among the new antibodies obtained, some were selected for further study. That panel includes a trophoblast specific antibody with capacity to differ between invasive and noninvasive molar tissues, and two antibodies, which detect antigen epitopes in the normal, but not in the neoplastic trophoblast. 相似文献
72.
M Dunér-Engstr?m O Larsson B B Fredholm L Lundblad J Fahrenkrug J M Lundberg 《Acta physiologica Scandinavica》1992,146(3):357-367
We have studied the effects of acute and long-term treatment of cats and rats with atropine on the levels, release and effects of two peptides, vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI), that probably co-exist with acetylcholine in the parasympathetic nerves supplying the submandibular gland. Atropine treatment (progressively increasing doses from 2 to 15 mg kg-1 injected s.c.) for 14 days did not alter the contents of VIP- or PHI-like immunoreactivity (-IR) in the cat submandibular gland or in three other tissues (nasal mucosa, trachea and tongue). Acute as well as long-term atropine treatment decreased the vasodilation following low-, but not high-, frequency parasympathetic nerve stimulation. During prolonged stimulation (60 min) there was a decreased vasodilatation response following both acute and long-term atropine treatment. The overflow of VIP-IR and PHI-IR following parasympathetic nerve stimulation was markedly increased by acute, but not by long-term atropine treatment. The VIP- or PHI-induced stimulation of cyclic AMP (cAMP) accumulation in the cat submandibular gland was not altered after long-term atropine treatment. Similarly, treatment of male Sprague-Dawley rats with atropine (20 mg kg-1) or imipramine (20 mg kg-1) for 14 days did not alter the sensitivity to VIP or to PHI of cAMP accumulation in the submandibular gland, nor was there any change in VIP-IR or PHI-IR content. In conclusion, although atropine treatment causes an acute increase in the overflow of VIP and PHI evoked by parasympathetic nerve stimulation, there is no depletion of peptide stores upon long-term treatment, nor is there any change in the effect of exogenous VIP and PHI on cAMP-accumulation. 相似文献
73.
Intrasplenic immunization with minute amounts of antigen 总被引:2,自引:0,他引:2
There are two ways to raise antibodies to minute amounts of immunogen. The first is in-vitro immunization in which the immunogen is presented to a spleen cell culture and about a week later cell fusion for hybridoma production is attempted. The second, and the subject of this review, is intrasplenic immunization, in which the immunogen is deposited into the spleen tissue and the animal itself takes care of growing the spleen cells. Both of these techniques are appropriate when only small amounts of immunogen are available. Intrasplenic immunization, however, requires less laboratory work and there is a decreased risk of contamination, often a problem with hybridoma cultures. The experience of intrasplenic immunization shows that it is the method of choice for immunization with nanogram amounts of immunogen. A successful outcome, however, requires that the immunogen is immobilized on a carrier. This review by Ove Nilsson and Anders Larsson will focus on the various types of matrix which can be used as carriers and on the procedures for transferring these carriers into the spleen tissue. 相似文献
74.
Spleen size in polycythemia. A clinical and scintigraphic study 总被引:1,自引:0,他引:1
75.
Strains of Proteus mirabilis and P. vulgaris isolated in England, Scotland and Sweden were characterised by proticine production-proticine sensitivity (P-S) typing, O serotyping and Dienes typing methods. The determinants of O antigenicity were independent of those determining proticine production and proticine sensitivity. Because of this independence, the combination of P-S typing and O serotyping for the analysis of the 133 serotypable strains separated them into 81 distinct types whereas P-S typing and O serotyping methods alone separated them into only 56 and 19 types respectively. There was a relationship between the Dienes type and the P-S type; the determinants of Dienes compatibility were the proticine production-proticine sensitivity characters. The determinants of O antigenicity appeared to play no role in the Dienes reaction. Some strains that were indistinguishable by P-S typing and O serotyping methods were distinguished by Dienes typing. 相似文献
76.
The present report describes a system where essentially all Lyt-2+ T cells are selectively activated by rabbit anti-mouse brain antibodies (RaMB) to interleukin 2 (IL 2) reactivity. High efficiency of RaMB-mediated induction was obtained by a 5 h incubation with antibodies at high cell density of Sephadex G-10-nonadherent spleen cells. No in situ production of IL 2 by RaMB-treated cells was detected, and proliferative responses were entirely dependent on exogeneous IL 2. RaMB-induced IL 2 reactivity was found to require accessory cells which are Fc receptor positive, and clearly distinct from those required to induce T cell proliferation in mixed lymphocyte cultures. We conclude that Lyt-2+ T cells are triggered to IL 2 reactivity by Fc receptor-mediated presentation of RaMB antibodies. The mechanism of induction by RaMB antibodies is discussed. 相似文献
77.
Larsson R. Liedholm H. Andersson K. E. Keane M. A. Henry G. 《European journal of clinical pharmacology》1986,29(5):549-553
Summary Milrinone, a new, nonglycosidic inotropic agent with peripheral vasodilating properties, was given as a single oral 5 mg dose to 7 healthy subjects, 7 patients with moderate renal impairment (CRI I, creatinine clearance 30–63 ml/min) and 7 patients with severe renal impairment (CRI II, creatinine clearance 9–29 ml/min). All except one of the patients with renal impairment had hypertension. The mean urinary recovery of milrinone was 82% in healthy subjects, the renal clearance was 288 ml/min and the plasma half-life (t1/2) was 0.94 h. In CRI the mean plasma t1/2 was prolonged (CRI I 1.78 h, CRI II 3.24 h). There was a significant linear relationship between creatinine clearance and the elimination rate constant, and between creatinine clearance and the renal clearance of milrinone. During the study day there was a tendency to a decrease in supine BP from 1 to 6–8 h after dosing, with the maximal decrease at 2–3 h (healthy subjects 118/71107/56, CRI 159/95136/79 mmHg). The same degree of change was seen in standing BP. A slight rise in standing HR was seen from 2–6 h after dosing. Changes in BP and HR are difficult to evaluate since the study was not placebo-controlled.The plasma elimination rate of milrinone was decreased in CRI and dose adjustment may be necessary. Placebo-controlled studies of milrinone in hypertensive patients would be required to validate its possible antihypertensive effect. 相似文献
78.
Carnitine is necessary for the transport of long-chain fatty acids across the mitochondrial membrane. Thirteen severely injured patients on total parenteral nutrition were studied during days 2-8 post injury. Initially plasma and skeletal muscle carnitine values were within the range earlier found for normal subjects, whereas the urinary carnitine excretion was markedly increased. On day 4 there was a simultaneous decrease in the carnitine concentration in plasma (alpha < 0.01) and urine (alpha < 0.05) as well as in skeletal muscle tissue (alpha < 0.05 using only the values that could be paired i.e. from eight subjects), whereas no difference was found between day 2 and 8. One explanation of this pattern might be that a redistribution of carnitine occurs to other organs not measured, for example the liver. In skeletal muscle tissue, statistically significant positive correlations were found between the carnitine level and ATP (alpha < 0.01) and phosphocreatine (alpha < 0.02) as well as between carnitine and glycogen (alpha < 0.05). 相似文献
79.
M. Larsson S. Landahl P. Lundborg C. G. Regårdh 《European journal of clinical pharmacology》1984,27(2):217-222
Summary The effect of long-term treatment on the absorption and dispsoition of metoprolol has been evaluated in 8 healthy, non-smoking, elderly individuals (mean age 74.5 years) and in a control group of 8 healthy, young individuals. Two trace doses of [3H]metoprolol were given i.v., first concomitantly with a single oral 50 mg dose of cold metoprolol, and second, with the morning dose after 2 weeks of treatment with 50 mg b.d. In the elderly, the mean AUC increased by about 45% (p<0.05) over the treatment period, while in the control group the mean AUC was 18% greater (p<0.05) on Day 14 than on Day 1. In the elderly, changes both in pre-systemic elimination and in total body clearance accounted for the elevation of the AUC, whereas reduced first-pass effect appeared to be the major cause of the increased steady-state plasma level in the control group. With the exception of the volume term, V
, the pharmacokinetic parameters were not significantly different between the elderly and the young individuals. For this reason, almost identical steady-state plasma levels were attained in the two groups. The results suggest that age-related physiological changes may have some minor effects on the pharmacokinetics of metoprolol, and also that the changes do not lead to significantly altered plasma concentrations compared to those in young individuals. 相似文献